共 50 条
- [1] Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19[J]. LUNG, 2023, 201 (02) : 159 - 170论文数: 引用数: h-index:机构:Stapleton, Renee D.论文数: 0 引用数: 0 h-index: 0机构: Univ Vermont, Pulm & Crit Care Med, Burlington, VT USA Univ Ferrara, Resp Dept, I-44100 Ferrara, ItalyShore, Paul M.论文数: 0 引用数: 0 h-index: 0机构: CSL Behring, Clin Dev, King Of Prussia, PA USA Univ Ferrara, Resp Dept, I-44100 Ferrara, ItalyBica, Mihai Alexandru论文数: 0 引用数: 0 h-index: 0机构: CSL Behring Innovat, Global Clin Safety & Pharmacovigilance, Marburg, Germany Univ Ferrara, Resp Dept, I-44100 Ferrara, ItalyChen, Younan论文数: 0 引用数: 0 h-index: 0机构: CSL Behring, Biostatistics, King Of Prussia, PA USA Univ Ferrara, Resp Dept, I-44100 Ferrara, ItalyLarbig, Michael论文数: 0 引用数: 0 h-index: 0机构: CSL Behring AG, Clin Dev, Bern, Switzerland Univ Ferrara, Resp Dept, I-44100 Ferrara, ItalyWelte, Tobias论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Dept Pulm & Infect Dis, Hannover, Germany Univ Ferrara, Resp Dept, I-44100 Ferrara, Italy
- [2] Efficacy and safety of garadacimab in patients with severe COVID-19[J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60Papi, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Ferrara, Resp Dept, Ferrara, Italy Univ Ferrara, Resp Dept, Ferrara, ItalyStapleton, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Vermont, Pulm & Crit Care Med, Burlington, VT USA Univ Ferrara, Resp Dept, Ferrara, ItalyShore, P. M.论文数: 0 引用数: 0 h-index: 0机构: CSL Behring, Clin Dev, King Of Prussia, PA USA Univ Ferrara, Resp Dept, Ferrara, ItalyBica, M. A.论文数: 0 引用数: 0 h-index: 0机构: CSL Behring Innovat, Global Clin Safety & Pharmacovigilance, Marburg, Germany Univ Ferrara, Resp Dept, Ferrara, ItalyChen, Y.论文数: 0 引用数: 0 h-index: 0机构: CSL Behring, Biostat, King Of Prussia, PA USA Univ Ferrara, Resp Dept, Ferrara, ItalyLarbig, M.论文数: 0 引用数: 0 h-index: 0机构: CSL Behring AG, Clin Dev, Bern, Switzerland Univ Ferrara, Resp Dept, Ferrara, ItalyWelte, T.论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Dept Pulm & Infect Dis, Hannover, Germany Univ Ferrara, Resp Dept, Ferrara, Italy
- [3] Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19[J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107Abbasian, Ladan论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranToroghi, Negar论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Sch Pharm, Dept Clin Pharm, Int Campus, Tehran 1417614411, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranRahmani, Hamid论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Sch Pharm, Dept Clin Pharm, Int Campus, Tehran 1417614411, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranKhalili, Hossein论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Sch Pharm, Dept Clin Pharm, Int Campus, Tehran 1417614411, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, Iran论文数: 引用数: h-index:机构:Ghiasvand, Fereshteh论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranJafari, Sirous论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranSalehi, Mohammadreza论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranSalahshour, Faeze论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Adv Diagnost & Intervent Radiol Res Ctr ADIR, Dept Radiol, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranGorabi, Mahsa Azadbakhsh Kanaf论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranAlizade, Fateme论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranGhaderkhani, Sara论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, IranNakhostin, Maryam论文数: 0 引用数: 0 h-index: 0机构: Univ Tehran Med Sci, Dept Infect Dis, Imam Khomeini Hosp Complex, Tehran, Iran Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Dept Infect Dis,Imam Khomeini Hosp Complex, Tehran, Iran
- [4] Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases[J]. PLOS ONE, 2023, 18 (11):Kaur, Harleen论文数: 0 引用数: 0 h-index: 0机构: Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaBawaskar, Ramesh论文数: 0 引用数: 0 h-index: 0机构: Reg Res Inst Homoeopathy, Navi Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKhobragade, Akash论文数: 0 引用数: 0 h-index: 0机构: St George Hosp, Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKalra, Dhiraj论文数: 0 引用数: 0 h-index: 0机构: YMT Dent Coll & Hosp, Navi Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaPackiam, Vedati论文数: 0 引用数: 0 h-index: 0机构: Rejoice Hlth Fdn, New Delhi, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKhan, Mohammed Yamin论文数: 0 引用数: 0 h-index: 0机构: Reg Res Inst Homoeopathy, Navi Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKaur, Twinkle论文数: 0 引用数: 0 h-index: 0机构: Reg Res Inst Homoeopathy, Navi Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaSharma, Manish论文数: 0 引用数: 0 h-index: 0机构: Reg Res Inst Homoeopathy, Navi Mumbai, Maharashtra, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaVerma, Naval Kumar论文数: 0 引用数: 0 h-index: 0机构: Rejoice Hlth Fdn, New Delhi, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKaushik, Subhash论文数: 0 引用数: 0 h-index: 0机构: Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, IndiaKhurana, Anil论文数: 0 引用数: 0 h-index: 0机构: Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, India Govt India, Minist AYUSH, Cent Council Res Homoeopathy, New Delhi, India
- [5] Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial[J]. JAMA NETWORK OPEN, 2023, 6 (04) : E237243Fanlo, Patricia论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, Spaindel Carmelo Gracia-Tello, Borja论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Clin Lozano Blesa, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Zaragoza, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainFonseca Aizpuru, Eva论文数: 0 引用数: 0 h-index: 0机构: Hosp Cabuenes, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Gijon, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainAlvarez-Troncoso, Jorge论文数: 0 引用数: 0 h-index: 0机构: Hosp La Paz, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Madrid, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainGonzalez, Andres论文数: 0 引用数: 0 h-index: 0机构: Hosp Ramon & Cajal, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Madrid, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainPrieto-Gonzalez, Sergio论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Serv Enfermedades Autoinmunes Sistem, Barcelona, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainFreire, Mayka论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Santiago, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Santiago De Compostela, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainBelen Argibay, Ana论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Vigo, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Vigo, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainPallares, Lucio论文数: 0 引用数: 0 h-index: 0机构: Hosp Son Espases, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Palma de Mallorca, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainAntonio Todoli, Jose论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Fe, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Valencia, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainPerez, Mercedes论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Miguel Servet, Unidad Enfermedades Autoinmunes Sistem, Serv Med Interna, Zaragoza, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainBujan-Rivas, Segundo论文数: 0 引用数: 0 h-index: 0机构: Hosp Valle De Hebron, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Barcelona, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, SpainIbanez, Berta论文数: 0 引用数: 0 h-index: 0机构: Univ Publ Navarra, Hosp Univ Navarra, Navarrabiomed, Red Invest & Cronicidad Atenc Primaria & Prevenc, Pamplona, Spain Hosp Univ Navarra, Serv Med Interna, Unidad Enfermedades Autoinmunes Sistem, Irunlarrea 3-4, Pamplona 31008, Spain
- [6] Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients[J]. PLOS ONE, 2020, 15 (11):Camprubi, Daniel论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainAlmuedo-Riera, Alex论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain论文数: 引用数: h-index:机构:Soriano, Alex论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Infect Dis Dept, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainHurtado, Juan Carlos论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Microbiol Dept, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainSubira, Carme论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainGrau-Pujol, Berta论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainKrolewiecki, Alejandro论文数: 0 引用数: 0 h-index: 0机构: Univ Nacl Salta, CONICET, Inst Invest Enfermedades Trop, Oran, Argentina Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, SpainMunoz, Jose论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain
- [7] Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19[J]. SCIENTIFIC REPORTS, 2022, 12 (01)Messina, Vincenzo论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyNevola, Riccardo论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Internal Med Covid Ctr, Dept Adv Med & Surg Sci, I-80100 Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyIzzi, Antonio论文数: 0 引用数: 0 h-index: 0机构: Osped Cotugno, Infect Dis, Covid Ctr 3, Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalySposito, Pellegrino De Lucia论文数: 0 引用数: 0 h-index: 0机构: Osped Maddaloni, COVID Ctr, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyMarrone, Aldo论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Internal Med Covid Ctr, Dept Adv Med & Surg Sci, I-80100 Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyRega, Roberto论文数: 0 引用数: 0 h-index: 0机构: Osped Cotugno, Infect Dis, Covid Ctr 3, Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyFusco, Raffaele论文数: 0 引用数: 0 h-index: 0机构: Osped Maddaloni, COVID Ctr, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyLumino, Paolina论文数: 0 引用数: 0 h-index: 0机构: Osped Cotugno, Infect Dis, Covid Ctr 3, Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyRinaldi, Luca论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Internal Med Covid Ctr, Dept Adv Med & Surg Sci, I-80100 Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyGaglione, Pasqualina论文数: 0 引用数: 0 h-index: 0机构: Osped Maddaloni, COVID Ctr, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalySimeone, Filomena论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalySasso, Ferdinando Carlo论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Internal Med Covid Ctr, Dept Adv Med & Surg Sci, I-80100 Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyMaggi, Paolo论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, ItalyAdinolfi, Luigi Elio论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Internal Med Covid Ctr, Dept Adv Med & Surg Sci, I-80100 Naples, Italy Azienda Osped Caserta S Anna & S Sebastiano, Infect Dis Unit, Caserta, Italy
- [8] Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19[J]. Scientific Reports, 12Vincenzo Messina论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitRiccardo Nevola论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitAntonio Izzi论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitPellegrino De Lucia Sposito论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitAldo Marrone论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitRoberto Rega论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitRaffaele Fusco论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitPaolina Lumino论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitLuca Rinaldi论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitPasqualina Gaglione论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitFilomena Simeone论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitFerdinando Carlo Sasso论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitPaolo Maggi论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease UnitLuigi Elio Adinolfi论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano,Infectious Disease Unit
- [9] Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients[J]. JOURNAL OF INFECTION, 2021, 82 (05) : 199 - 200Chen, Ping-Jen论文数: 0 引用数: 0 h-index: 0机构: Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan Chi Mei Med Ctr, Dept Surg, Tainan, TaiwanChao, Chien-Ming论文数: 0 引用数: 0 h-index: 0机构: Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan Chi Mei Med Ctr, Dept Surg, Tainan, TaiwanLai, Chih-Cheng论文数: 0 引用数: 0 h-index: 0机构: Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med, Tainan, Taiwan Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan
- [10] Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial[J]. TRIALS, 2021, 22 (01)Pourdowlat, Guitti论文数: 0 引用数: 0 h-index: 0机构: Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, IranMousavinasab, Seyed Ruhollah论文数: 0 引用数: 0 h-index: 0机构: Shiraz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Shiraz, Iran Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, IranFarzanegan, Behrooz论文数: 0 引用数: 0 h-index: 0机构: SBMU, Crit Care Qual Improvement Res Ctr, Tehran, Iran Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran论文数: 引用数: h-index:机构:Meybodi, Zohreh Akhoundi论文数: 0 引用数: 0 h-index: 0机构: Shahid Sadoughi Univ Med Sci, Yazd, Iran Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, IranJafarzadeh, Maedeh论文数: 0 引用数: 0 h-index: 0机构: Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran论文数: 引用数: h-index:机构: